[1]
2025. Long-term Clinical Efficacy and Safety of Thalidomide in Patients with Transfusion‑dependent β‑thalassemia Major. Indus Journal of Bioscience Research. 3, 1 (Jan. 2025), 784–791. DOI:https://doi.org/10.70749/ijbr.v3i1.595.